Results 1 to 10 of about 2,984,799 (310)

Antiepileptic Drug-Related Adverse Reactions and Factors Influencing These Reactions [PDF]

open access: yesIranian journal of child neurology, 2013
How to Cite This Article: Karimzadeh P, Bakrani V. Antiepileptic Drug-Related Adverse Reactions And Factors Influencing These Reactions. Iran J Child Neurol. 2013 Summer; 7(3):23-27.
BAKRANI, Vahid, KARIMZADEH, Parvaneh
core   +4 more sources

Individualized versus standardized risk assessment in patients at high risk for adverse drug reactions (IDrug) – study protocol for a pragmatic randomized controlled trial [PDF]

open access: yes, 2016
Background Elderly patients are particularly vulnerable to adverse drug reactions, especially if they are affected by additional risk factors such as multimorbidity, polypharmacy, impaired renal function and intake of drugs with high risk potential ...
A Benard-Laribiere   +53 more
core   +2 more sources

Early and Late Side Effects Associated with Photo(chemo)therapy [PDF]

open access: yes, 2010
Phototherapy (PUVA ve UVB) is a widely used and effective treatment method for a variety of dermatological diseases. Adverse effects associated with phototherapy can be classified as acute and chronic side effects.
Günseli Öztürk
core   +1 more source

IMPORTANCE OF NANOCARRIERS AND PROBIOTICS IN THE TREATMENT OF ULCERATIVE COLITIS [PDF]

open access: yes, 2021
Ulcerative colitis (UC) is an inflammatory chronic disease primarily affecting the colonic mucosa; the extent and severity of colon involvement are variable. Ulcerative colitis is identified by mucus diarrhea, tenesmus, bowel distension, and anemia.
KUMAR, ARVIND   +7 more
core   +1 more source

Impact of polymorphisms in transporter and metabolizing enzyme genes on olanzapine pharmacokinetics and safety in healthy volunteers [PDF]

open access: yes, 2020
Olanzapine is an atypical antipsychotic widely used for the treatment of schizophrenia, which often causes serious adverse drug reactions. Currently, there are no clinical guidelines implementing pharmacogenetic information on olanzapine.
Abad-Santos, Francisco   +11 more
core   +1 more source

WITHDRAWN-a resource for withdrawn and discontinued drugs [PDF]

open access: yes, 2015
Post-marketing drug withdrawals can be associated with various events, ranging from safety issues such as reported deaths or severe side-effects, to a multitude of non-safety problems including lack of efficacy, manufacturing, regulatory or business ...
Drwal, M.N.   +5 more
core   +3 more sources

Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998–2005 [PDF]

open access: yes, 2007
BACKGROUND: Adverse drug reactions (ADRs) are a frequent cause of mortality and morbidity to patients worldwide, with great associated costs to the healthcare providers including the NHS in England.
Bell, Derek   +6 more
core   +3 more sources

A randomized comparison between lercanidipine and amlodipine for efficacy and tolerability in patients with essential hypertension [PDF]

open access: yes, 2016
Background: Lercanidipine, a newly added dihydropyridine, was compared with one of its older and time tested congener- amlodipine for their efficacy and tolerability.Methods: This was a prospective, double blind, parallel group study.
Choure, Balwant Kisanrao   +3 more
core   +3 more sources

GraphSAW: A web-based system for graphical analysis of drug interactions and side effects using pharmaceutical and molecular data [PDF]

open access: yes, 2015
Shoshi A, Hoppe T, Kormeier B, Ogultarhan V, Hofestädt R. GraphSAW: A web-based system for graphical analysis of drug interactions and side effects using pharmaceutical and molecular data. BMC Medical Informatics and Decision Making.
Hofestädt, Ralf   +4 more
core   +2 more sources

Management of Immune-Related Adverse Events from Immune-Checkpoint Inhibitors in Advanced or Metastatic Renal Cell Carcinoma [PDF]

open access: yes, 2022
Simple Summary Today, most patients with metastatic renal cancer receive systemic treatment with so-called immune-checkpoint inhibitors that shall activate a patient’s immune system.
Ali, Nalyan   +3 more
core   +2 more sources

Home - About - Disclaimer - Privacy